‌

US Patent 8697627 Compositions and methods for treating alzheimer's disease

Patent 8697627 was granted and assigned to EIP Pharma on April, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

EIP Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86976270

Patent Inventor Names

John Jahangir Alam0

Date of Patent

April 15, 2014

Patent Application Number

134675190

Date Filed

May 9, 2012

Patent Citations Received

‌

US Patent 11969412 Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza

Patent Primary Examiner

‌

Daniel E Kolker

Patent abstract

The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8697627 Compositions and methods for treating alzheimer's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API